Dashboard
Manage Tickers

ALEC Alector, Inc.

Nasdaq alector.com


$ 1.69 $ 0.14 (9.42 %)    

Wednesday, 22-Oct-2025 14:06:27 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 601.99 $ -8.84 (-1.45 %)
DIA $ 465.27 $ -3.95 (-0.84 %)
SPY $ 665.18 $ -6.68 (-0.99 %)
TLT $ 92.08 $ 0.09 (0.1 %)
GLD $ 375.02 $ 2.15 (0.56 %)
$ 3.21
$ 1.54
$ 1.68 x 1,453
$ 1.69 x 5,086
$ 1.50 - $ 1.70
$ 0.87 - $ 6.14
4,470,697
na
324.89M
$ 1.59
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-08-2025 03-31-2025 10-Q
3 02-26-2025 12-31-2024 10-K
4 11-06-2024 09-30-2024 10-Q
5 08-07-2024 06-30-2024 10-Q
6 05-08-2024 03-31-2024 10-Q
7 02-27-2024 12-31-2023 10-K
8 11-07-2023 09-30-2023 10-Q
9 08-03-2023 06-30-2023 10-Q
10 05-04-2023 03-31-2023 10-Q
11 02-28-2023 12-31-2022 10-K
12 11-08-2022 09-30-2022 10-Q
13 08-04-2022 06-30-2022 10-Q
14 05-05-2022 03-31-2022 10-Q
15 02-24-2022 12-31-2021 10-K
16 11-04-2021 09-30-2021 10-Q
17 08-03-2021 06-30-2021 10-Q
18 05-05-2021 03-31-2021 10-Q
19 02-25-2021 12-31-2020 10-K
20 11-10-2020 09-30-2020 10-Q
21 08-11-2020 06-30-2020 10-Q
22 05-13-2020 03-31-2020 10-Q
23 03-24-2020 12-31-2019 10-K
24 11-12-2019 09-30-2019 10-Q
25 08-12-2019 06-30-2019 10-Q
26 05-13-2019 03-31-2019 10-Q
27 03-26-2019 12-31-2018 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

crude-oil-gains-over-1-att-shares-slide-after-q3-results
Crude Oil Gains Over 1%; AT&T Shares Slide...
10/22/2025 17:13:45

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/22/2025 17:06:27

clinical-failure-halts-alectors-dementia-program-company-reduces-workforce
Clinical Failure Halts Alector's Dementia ...
10/22/2025 16:07:31

Alector's Phase 3 trial for FTD-GRN drug, latozinemab, failed the clinical co-primary endpoint. The program is discontinued...

td-cowen-downgrades-alector-to-hold
TD Cowen Downgrades Alector to Hold
10/22/2025 15:12:04

TD Cowen analyst Yaron Werber downgrades Alector (NASDAQ:ALEC) from Buy to Hold.

cantor-fitzgerald-downgrades-alector-to-neutral
Cantor Fitzgerald Downgrades Alector to Ne...
10/22/2025 15:02:00

Cantor Fitzgerald analyst Pete Stavropoulos downgrades Alector (NASDAQ:ALEC) from Overweight to Neutral.

hc-wainwright--co-maintains-buy-on-alector-lowers-price-target-to-5
HC Wainwright & Co. Maintains Buy on Alect...
10/22/2025 14:39:23

HC Wainwright & Co. analyst Andrew Fein maintains Alector (NASDAQ:ALEC) with a Buy and lowers the price target from $10 ...

dow-falls-100-points-netflix-shares-tumble-on-downbeat-earnings
Dow Falls 100 Points; Netflix Shares Tumbl...
10/22/2025 14:12:32

netflix-posts-downbeat-earnings-joins-aveanna-healthcare-texas-instruments-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session
Netflix Posts Downbeat Earnings, Joins Ave...
10/22/2025 12:16:12

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/22/2025 12:09:33

william-blair-downgrades-alector-to-market-perform
William Blair Downgrades Alector to Market...
10/22/2025 11:28:56

William Blair analyst Myles Minter downgrades Alector (NASDAQ:ALEC) from Outperform to Market Perform.

btig-downgrades-alector-to-neutral
BTIG Downgrades Alector to Neutral
10/22/2025 11:06:54

BTIG analyst Thomas Shrader downgrades Alector (NASDAQ:ALEC) from Buy to Neutral.

why-intuitive-surgical-shares-are-trading-higher-by-around-16-here-are-20-stocks-moving-premarket
Why Intuitive Surgical Shares Are Trading ...
10/22/2025 09:55:35

att-netflix-and-3-stocks-to-watch-heading-into-wednesday
AT&T, Netflix And 3 Stocks To Watch Headin...
10/22/2025 08:31:12

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
10/21/2025 21:06:33

alector-says-workforce-reduction-impacts-about-75-employees-restructuring-charges-expected-to-be-about-77m
Alector Says Workforce Reduction Impacts A...
10/21/2025 20:42:24

- SEC Filing

alector-discontinues-open-label-extension-for-latozinemab-co-to-reduce-workforce-by-about-49
Alector Discontinues Open-Label Extension ...
10/21/2025 20:35:28

Alector Pipeline OutlookAlector remains focused on advancing a pipeline of programs designed to treat neurodegenerative disease...

trading-halt-halt-status-updated-at-43000-pm-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 4:30:...
10/21/2025 20:30:10

alector-reports-in-96-week-double-blind-infront-3-trial-latozinemab-developed-in-collaboration-with-gsk-did-not-meet-clinical-co-primary-endpoint-of-slowing-ftd-grn-progression
Alector Reports In 96-Week, Double-Blind I...
10/21/2025 20:10:43

alector-reports-topline-results-latozinemab-phase-3-trial-in-individuals-with-frontotemporal-dementia-due-to-grn-mutation
Alector Reports Topline Results Latozinema...
10/21/2025 20:08:17

trading-halt-halted-at-40100-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 4:01:00 p.m. ET - ...
10/21/2025 20:01:04

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION